Game Changing Research

Last year, we unveiled a brand-new research strategy, ‘Taking on research to change the future’, which lays out our roadmap for achieving our ambition of doubling the UK survival rate for people with pancreatic cancer.

We invested over £2.4 million in ground-breaking research, more than ever before.This included launching our £1m Pancreatic Cancer UK Grand Challenge Award, daring the very best researchers and doctors to take on the toughest aspects of the disease.

We investigated a new early diagnosis test

We investigated a new early diagnosis test

With our funding, Professor Zhengming Chen and Dr Michael Holmes were able to begin researching a new blood test to diagnose pancreatic cancer at an early stage.They hope that the test could be used to identify individuals with pancreatic cancer before they start to experience symptoms, which could allow more people to have surgery and save more lives.


We set up a new Academy for Future Leaders

We set up a new Academy for Future Leaders

Last year, we established the first Pancreatic Cancer UK Future Leaders Academy at the Beatson Institute in Glasgow, which is due to go live in October 2017.

With £500,000 in funding, Professor Owen Sansom will be leading the Academy and will be supported by a team of world-class investigators. Together, they will provide support, training and mentoring for a group of new students who we hope will become world-leading scientists, and who can bring the breakthroughs of the future to fruition.


We worked to discover new pancreatic cancer drugs

We worked to discover new pancreatic cancer drugs

We funded Professor Weiguang Wang, who began work investigating whether a drug that is currently used to stop alcoholics craving a drink could be used to treat pancreatic cancer. By testing a drug that is cheap, safe and already in use, it is hoped that people with pancreatic cancer could start bene ting from the treatment much quicker, even within just a few years.